doi: 10.1016/S1359-6446(04)03332-X.
Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney
Affiliations
- PMID: 15708528
- DOI: 10.1016/S1359-6446(04)03332-X
Item in Clipboard
Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney
Drug Discov Today.
.
No abstract available
Similar articles
-
[Pharmacological possibilities in the treatment of brain injuries. Correct choice of drugs can optimize rehabilitation].Lakartidningen. 2007 Aug 29-Sep 4;104(35):2422-6. Lakartidningen. 2007. PMID: 17902412 Review. Swedish. No abstract available.
-
Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.Psychopharmacol Bull. 1988;24(1):31-8. Psychopharmacol Bull. 1988. PMID: 3290945 Review. No abstract available.
-
Drug development for CNS disorders: strategies for balancing risk and reducing attrition.Nat Rev Drug Discov. 2007 Jul;6(7):521-32. doi: 10.1038/nrd2094. Nat Rev Drug Discov. 2007. PMID: 17599084 Review.
-
Rofecoxib in mild cognitive impairment.Curr Psychiatry Rep. 2006 Feb;8(1):9-10. Curr Psychiatry Rep. 2006. PMID: 16513035 Clinical Trial. No abstract available.
-
Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.Prog Clin Biol Res. 1989;317:1111-20. Prog Clin Biol Res. 1989. PMID: 2690088 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
